<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    NeuroMetrix, Inc.

    NeuroMetrix, Inc.

    Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and ...

    Founded in 1996 as a spinoff from the Harvard-M...

    Filing Type:    PU
    Motif Bio plc

    Motif Bio plc

    Motif Bio is a clinical stage biopharmaceutical company developing novel antibioti...

    Motif Bio is a clinical stage biopharmaceutical...

    Filing Type:    PU
    Fresenius SE & Co. KGaA

    Fresenius SE & Co. KGaA

    Fresenius is a global healthcare group offering high-quality products and services...

    Fresenius is a global healthcare group offering...

    Filing Type:    PU
    BioSpecifics Technologies Corp

    BioSpecifics Technologies Corp

    BioSpecifics Technologies Corp. is a biopharmaceutical company that is the origina...

    BioSpecifics Technologies Corp. is a biopharmac...

    Filing Type:    PU
    H & G Science, Inc.

    H & G Science, Inc.

    H&G Science aims to facilitate the safe and effective treatment of diseases. Our g...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Alterity Therapeutics Limited

    Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative di...

    We exist to create an alternate future for peop...

    Filing Type:    PU
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    LifeBridge 10000, LLC

    LifeBridge 10000, LLC

    LifeBridge 10000, LLC specializes in extending and improving the quality of life f...

    LifeBridge 10000, LLC specializes in extending ...

    Amount Raised:    $23,091.00
    Fundraising Status:    EC
    Filing Type:    CF
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.